NXGL

Conviction 20HealthcareScan · Mon, Aug 10, 2026

Bullish harami

NXGL$0.3800+12.09%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 67.26K

May 8May 27Jun 15Jul 2Jul 22Aug 7

NEXGEL, INC.SURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.nexgel.com ↗

Price0.3800

Change+12.09%

Gap+0.53%

Rel volume2.18×

Avg volume84.56K

Avg $ vol35.32K

SMA 200.4311

SMA 500.5069

SMA 2001.10

Price vs 50-25.03%

Price vs 200-65.54%

MA stackbearish

50/200 cross—

Supertrenddown · 0.4942

RSI (14)37

MACD hist-0.00

MACD crossbear · 1d

Stoch %K / %D35 / 19

ADX (14)26

+DI / −DI9 / 27

RSI divergence—

MACD divergence—

ATR %+11.71%

ADR %8.90%

52w high2.78

52w low0.3390

From 52w high-86.33%

Above 52w low+12.09%

New 52w highNo

SqueezeOn · 1d

Bollinger width28.32%

%B0.08

Donchian pos27.84%

Donchian high0.5088

Donchian low0.3303

AVWAP (52w high)0.8763

vs AVWAP high-56.64%

AVWAP (52w low)0.3629

vs AVWAP low+4.70%

OBV trendDown

Chaikin MF (20)-0.29

Today vs 20d2.18×

Avg vol (14d)67.25K

Avg vol (20d)84.56K

Avg $ vol (20d)35.32K

Market cap—

RS 3m (vs SPY)-43.91%

RS 6m (vs SPY)-82.71%

RS line new highNo

Trend template0/8

Technical rank3.2

1 week-8.46%

1 month-26.11%

3 months-38.21%

6 months-68.60%

1 year-85.04%

YTD-79.01%

P/E-1.20

P/B0.90

P/S0.32

P/FCF-2.62

EPS-0.3800

Div yield—

ROE-75.11%

ROA-25.87%

Debt/Eq0.23

Current1.70

EV/EBITDA-1.23

Gross margin39.48%

Net margin-26.27%

Rev growth31.46%

EPS growth8.56%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value3.58M

Revenue2.65M

Net income-927K

Gross profit1.06M

Free cash flow-1.38M

IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS

ExchangeNasdaq

Shares out9.23M

Employees19

ListedWed, Dec 22, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction20 / 100

Pattern quality—

Tech rank3.2 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish harami

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NXGL

All disclosures →

No recent disclosed trades by Congress in NXGL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NXGL · 4 buys · 6 sells

Insider	Side	Shares	Value	Traded	Filed
Levy Adam R. Chief Executive Officer · Common Stock · 2026-06-08	Sell	3K	$2K	2026-06-08	2026-06-09
Levy Adam R. Chief Executive Officer · Common Stock · 2026-06-04	Sell	3K	$2K	2026-06-04	2026-06-09
Levy Adam R. Chief Executive Officer · Common Stock · 2026-06-01	Sell	2K	$1K	2026-06-01	2026-06-03
Levy Adam R. Chief Executive Officer · Common Stock · 2026-05-29	Sell	3K	$2K	2026-05-29	2026-05-29
Levy Adam R. Chief Executive Officer · Common Stock · 2026-05-28	Sell	7K	$4K	2026-05-28	2026-05-29
Levy Adam R. Chief Executive Officer · Common Stock · 2026-05-27	Sell	3K	$2K	2026-05-27	2026-05-29
Henry Scott Robert Director · Warrant to Purchase Common Stock (the "Warrant") · 2026-05-14	Buy	20.83K	$0	2026-05-14	2026-05-18
Henry Scott Robert Director · Convertible Promissory Note (the "Note") · 2026-05-14	Buy	41.67K	$25K	2026-05-14	2026-05-18
Levy Adam R. Chief Executive Officer · Convertible Promissory Note (the "Note") · 2026-05-14	Buy	100K	$60K	2026-05-14	2026-05-18
Levy Adam R. Chief Executive Officer · Warrant to Purchase Common Stock (the "Warrant") · 2026-05-14	Buy	50K	$0	2026-05-14	2026-05-18

SEC filings

EDGAR filings in NXGL · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.